EUVIMEDOpdag EUVIMED
Crossref

Progranulin mitigates intestinal injury in a murine model of necrotizing enterocolitis by suppressing M1 macrophage polarization

Dandan Mo, Youjun Qiu, Bing Tian, Xinli Liu, Yujie Chen, Guotao Zou, Chunbao Guo, Chun Deng

Cell Biology International · 2024

DOI: 10.1002/cbin.12209 ↗

At a glance

Journal article in Cell Biology International, 2024. Written by Dandan Mo and 7 co-authors. Institution: Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Chongqin, China. Major MEDLINE topics: Enterocolitis, Necrotizing, Macrophages, Progranulins. Cited 2 times so far (Crossref); 40 references. Funded by: Key project of the Chongqing Natural Science Foundation, Chongqing Graduate Research Innovation Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Neonatal necrotizing enterocolitis (NEC) is a critical digestive disorder frequently affecting premature infants. Characterized by intestinal inflammation caused by activated M1 macrophages, modulation of macrophage polarization is considered a promising therapeutic strategy for NEC. It has been demonstrated that the growth factor‐like protein progranulin (PGRN), which plays roles in a number of physiological and pathological processes, can influence macrophage polarization and exhibit anti‐inflammatory characteristics in a number of illnesses. However, its role in NEC is yet to be investigated. Our research showed that the levels of PGRN were markedly elevated in both human and animal models of NEC. PGRN deletion in mice worsens NEC by encouraging M1 polarization of macrophages and escalating intestinal damage and inflammation. Intravenous administration of recombinant PGRN to NEC mice showed significant survival benefits and protective effects, likely due to PGRN's ability to inhibit M1 polarization and reduce the release of pro‐inflammatory factors. Our findings shed new light on PGRN's biological role in NEC and demonstrate its potential as a therapeutic target for the disease.

Subjects

MeSH terms (MEDLINE)

Enterocolitis, NecrotizingMacrophagesProgranulinsAnimalsFemaleHumansMaleMiceAnimals, NewbornDisease Models, AnimalInflammationIntestinal MucosaIntestinesMice, Inbred C57BLMice, Knockout

Author keywords

inflammationmacrophagesnecrotizing enterocolitisprogranulin

Substances

Grn protein, mouseProgranulins

Authors and institutions

  • Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Chongqin, China.
  • School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
  • Department of Pediatrics, Chongqing Health Center for Women and Children, Chongqing, China.
  • Department of Pediatric Surgery, Women's and Children's Hospital of Chongqing Medical University, Chongqing, China.

Funding

  • Key project of the Chongqing Natural Science Foundation
  • Chongqing Graduate Research Innovation Project

Cite

APA

Mo, D., Qiu, Y., Tian, B., Liu, X., Chen, Y., Zou, G., Guo, C., & Deng, C. (2024). Progranulin mitigates intestinal injury in a murine model of necrotizing enterocolitis by suppressing M1 macrophage polarization. Cell Biology International. https://doi.org/10.1002/cbin.12209

Vancouver

Mo D, Qiu Y, Tian B, Liu X, Chen Y, Zou G, et al. Progranulin mitigates intestinal injury in a murine model of necrotizing enterocolitis by suppressing M1 macrophage polarization. Cell Biology International. 2024. doi:10.1002/cbin.12209

BibTeX
@article{Mo2024,
  author = {Mo, Dandan and Qiu, Youjun and Tian, Bing and Liu, Xinli and Chen, Yujie and Zou, Guotao and Guo, Chunbao and Deng, Chun},
  title = {Progranulin mitigates intestinal injury in a murine model of necrotizing enterocolitis by suppressing M1 macrophage polarization},
  journal = {Cell Biology International},
  year = {2024},
  doi = {10.1002/cbin.12209}
}
Start for free →